Sacubitril-Valsartan Increases Ultrafiltration in Patients Undergoing Peritoneal Dialysis: A Short-Term Retrospective Self-Controlled Study

AIM: There are few data about the effectiveness and safety of angiotensin receptor-neprilysin inhibitor (ARNI) sacubitril-valsartan in end-stage renal disease (ESRD) patients undergoing peritoneal dialysis (PD). The present study was conducted to evaluate the association between sacubitril-valsartan...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Fen, Zhang, Tingting, Yang, Sisi, Wang, Di, Zhuo, Qianqian, Qin, Xianhui, Gong, Nirong, Ai, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9203730/
https://www.ncbi.nlm.nih.gov/pubmed/35721096
http://dx.doi.org/10.3389/fmed.2022.831541

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9203730/
https://www.ncbi.nlm.nih.gov/pubmed/35721096
http://dx.doi.org/10.3389/fmed.2022.831541

Ejemplares similares